
LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery.
Listed
From LiliumX's own website: 2 founders, 16 on the team.
Add your raise, your deck and your story, and put LiliumX in front of investors. Or tell us what we have wrong.